Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ED90 of Norepinephrine and Phenylephrine for Prevention of Maternal Hypotension
NCT07894783Not yet recruiting
- Sponsor
- General Hospital of Ningxia Medical University
- Start
- Jan 2027
- Primary completion
- Jan 2027
01
Overview
Randomised trial in hypotension comparing Norepinephrine group with Phenylephrine group (2 arms). Primary endpoint: 90% Effective Dose. Planned start Jan 2027; status: not yet recruiting.
02
Drugs
norepinephrinephenylephrine
03
Conditions
hypotension
Beyond the preview
Go deeper on NCT07894783.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07894783.